Praxis Precision Medicines (PRAX)
(Delayed Data from NSDQ)
$42.22 USD
-3.01 (-6.65%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $42.70 +0.48 (1.14%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth F Momentum F VGM
Fundamental Charts
About Dividend Yield (TTM)
Praxis Precision Medicines, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
PRAX 42.22 -3.01(-6.65%)
Will PRAX be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for PRAX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for PRAX
Praxis Precision Medicines, Inc. (PRAX) Reports Q4 Loss, Tops Revenue Estimates
IGM Biosciences, Inc. (IGMS) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release
PRAX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Praxis Precision Medicines, Inc. (PRAX) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release
Ensign Group (ENSG) Q4 Earnings and Revenues Beat Estimates
Praxis Precision Medicines, Inc. (PRAX) Reports Q3 Loss, Misses Revenue Estimates
Other News for PRAX
PRAX Fell Below 20 Day Moving Average on September 19
Crossed Above 20 Day Moving Average appears for PRAX after 2.73% move
Is PRAX ready to move higher? Directional Movement Crossover Bullish shows up after climbing 4.83%
PRAX Coverage Initiated by Jones Trading with Buy Rating | PRAX Stock News
H.C. Wainwright Remains a Buy on Praxis Precision Medicines (PRAX)